Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2016 May-Jun;18(3):147-53.
doi: 10.7224/1537-2073.2015-008.

Symptomatic Management of Multiple Sclerosis-Associated Tremor Among Participants in the NARCOMS Registry

William Meador  1 , Amber R Salter  1 , John R Rinker 2nd  1
Affiliations

Symptomatic Management of Multiple Sclerosis-Associated Tremor Among Participants in the NARCOMS Registry

William Meador et al. Int J MS Care. 2016 May-Jun.

Abstract

Background: Tremor affects 25% to 58% of patients with multiple sclerosis (MS) and is associated with poor prognosis and increased disability. MS-related tremor is difficult to treat, and data regarding patient-reported characterization and response to treatment are limited. We describe the symptomatic treatment of tremor in 508 enrollees in the North American Research Committee on Multiple Sclerosis (NARCOMS) Registry who self-reported tremor.

Methods: From 777 surveys sent to NARCOMS participants who indicated mild or greater tremor using the Tremor and Coordination Scale, we compiled data regarding disability, tremor severity, symptomatic medication use, and reported response to medications.

Results: Symptomatic medications reported to reduce tremor were used by 238 respondents (46.9%). Symptomatic medication use was associated with increased rates of unemployment and disability, and many other characteristics were similar between groups. Symptomatic drug use was more likely in participants reporting moderate (53.9%) or severe (51.3%) tremor than in those with mild (36.6%) or totally disabling (35.0%) tremor. This disparity held true across multiple tremor severity scores. The most commonly used drug classes were anticonvulsants (50.8%) and benzodiazepines (46.2%), with gabapentin and clonazepam used most often in their respective classes.

Conclusions: Tremor in MS remains poorly treated; less than half of the participants reported benefit from symptomatic medications. Patients with moderate-to-severe tremor are more likely to report tremor benefit than are those with mild or disabling tremor. γ-Aminobutyric acid-active medications were most commonly reported as beneficial.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Recruitment flowchart MS, multiple sclerosis.
Figure 2.
Figure 2.
Symptomatic medication use by Tremor and Coordination Scale severity
Figure 3.
Figure 3.
Number of respondents using at least one medication reporting improved tremor by drug category
See this image and copyright information in PMC

References

    1. Goodman AD, Brown TR, Krupp LB et al. Sustained-release oral fampridine in multiple sclerosis: a randomized, double-blind, controlled trial. Lancet. 2009;373:732–738. - PubMed
    1. Panitch HS, Thisted RA, Smith RA et al. Randomized, controlled trial of dextromethorphan/quinidine for pseudobulbar affect in multiple sclerosis. Ann Neurol. 2006;59:780–787. - PubMed
    1. Pittock S, McClelland R, Mayr W et al. Prevalence of tremor in multiple sclerosis and associated disability in the Olmsted County population. Mov Disord. 2004;19:1482–1485. - PubMed
    1. Alusi SH, Worthington J, Glickman S et al. A study of tremor in multiple sclerosis. Brain. 2001;124:720–730. - PubMed
    1. Koch M, Mostert J, Heersema D et al. Tremor in multiple sclerosis. J Neurol. 2007;254:133–145. - PMC - PubMed

LinkOut - more resources